BIRC5 and diffuse large B-cell lymphoma: Interestingly, survivin overexpression was not in any significant correlation with other, well-established clinicopathological prognostic parameters in DLBCL: clinical stage, IPI, “bulky” disease, proliferative activity and extranodal localization.